Facial Masking for Covid-19 — Potential for “Variolation” as We Await a Vaccine

Increasing the proportion of SARS-CoV-2 infections that are asymptomatic with the simple public health measure of universal masking might help make the infection less deadly and increase population-level immunity without severe illnesses and deaths.

Saved in:
Bibliographic Details
Published inNew England Journal of Medicine Vol. 383; no. 18; p. e101
Main Authors Gandhi, Monica, Rutherford, George W
Format Journal Article Web Resource
LanguageEnglish
Published United States Massachusetts Medical Society 29.10.2020
Subjects
Asymptomatic
Asymptomatic Infections
Betacoronavirus
Communicable Disease Control - methods
Coronavirus Infections - prevention & control
Coronaviruses
COVID-19
COVID-19 vaccines
Disease transmission
Epidemics
Fatalities
Humans
Hypotheses
Immunity, Cellular
Immunization
Infections
Masks
Pandemics
Pandemics - prevention & control
Pathogenesis
Pneumonia, Viral - prevention & control
Population
Public health
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Smallpox
Viral infections
Viruses
United States > US
Online AccessGet full text

Cover

More Information
Summary:Increasing the proportion of SARS-CoV-2 infections that are asymptomatic with the simple public health measure of universal masking might help make the infection less deadly and increase population-level immunity without severe illnesses and deaths.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMp2026913